Evaluation of the Use of Metal Stents as Part of the Treatment of Benign Biliary Strictures

August 31, 2015 updated by: University of Florida

Prospective Evaluation of the Clinical Utility of Placement of Metal Stent for Benign Biliary Strictures

The purpose of this study is to study the evaluation of the use of metal stents as part of the treatment of benign biliary strictures.

Study Overview

Detailed Description

In patients with benign biliary strictures, the use of fully covered self-expandable metal stents (SEMS) has been proposed as an alternative to plastic stenting, but high quality prospective data is sparse. This study was performed to evaluate the long -term effectiveness and safety of a new fully covered SEMS for benign biliary strictures.

Study Type

Observational

Enrollment (Actual)

23

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Gainesville, Florida, United States, 32608
        • Shands at UF endoscopy center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who have a medical indication for endoscopic therapy of benign biliary stictures and are referred for the procedure as part of their standard medical care will be considered for the study.

Description

Inclusion Criteria:

  1. Subject is 18 years or older
  2. Subject has benign biliary stricture
  3. Subject must be able to give informed consent

Exclusion Criteria:

  1. Any contraindication to Endoscopic Retrograde Cholangiopancreatography (ERCP)
  2. The subject is unable to give informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
benign biliary strictures
All patients who have a medical indication for an ERCP to place a stent in their benign biliary strictures
Endoscopic Retrograde Cholangiopancreatography (ERCP) with placement of metal stent in the bile duct

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Short Term Success Rate in the Resolution of Biliary Strictures
Time Frame: 6 months
Short-term success was defined as resolution of the stricture as documented by rapid drainage of contrast out of the proximal biliary tree and easy passage of stone extraction balloon inflated to the size of the proximal bile duct. If the biliary stricture had resolved at the 6-month follow-up ERCP, patients were classified as short-term success. If stricture was not resolved at 6-month ERCP then a new SEMS was placed; if the stricture had resolved at the time of the second stent removal, the patient was also classified as short-term success.
6 months
Long-term Success Rate in Resolution of Biliary Strictures
Time Frame: at least 12 months after stent removal
Long-term success was defined as no clinical evidence of recurrence of the biliary stricture during the follow-up period as documented by laboratory findings or imaging and no further need for further endoscopic or surgical interventions.
at least 12 months after stent removal

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Endoscopic Treatments Per Patient
Time Frame: At time of procedure
The average number of ERCPs performed per patient required for resolution of benign strictures.
At time of procedure
Ease of Stent Removal
Time Frame: at time of procedure
The ease of stent removal was graded on a 4-point scale (with ease, mild difficulty, significant difficulty, and failed).
at time of procedure
Frequency and Severity of Adverse Events (Including Stent Migration)
Time Frame: up to 12 months
Adverse events were defined and graded using the 2010 American Society for Gastrointestinal Endoscopy consensus criteria
up to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2009

Primary Completion (Actual)

May 1, 2015

Study Completion (Actual)

May 1, 2015

Study Registration Dates

First Submitted

November 5, 2010

First Submitted That Met QC Criteria

November 9, 2010

First Posted (Estimate)

November 11, 2010

Study Record Updates

Last Update Posted (Estimate)

October 2, 2015

Last Update Submitted That Met QC Criteria

August 31, 2015

Last Verified

August 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Benign Biliary Strictures

Clinical Trials on Endoscopic Retrograde Cholangiopancreatography (ERCP)

Subscribe